Holocene Advisors, LP Sarepta Therapeutics, Inc. Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $1.26 Million - $1.52 Million	12,264 New	12,264 $1.49 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $22.6 Million - $32.4 Million	-357,926 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $1.77 Million - $2.28 Million	-22,960 Reduced 6.03%	357,926 $32.2 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $25.1 Million - $35.2 Million	380,886 New	380,886 $35.2 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $24.1 Million - $44.5 Million	-258,897 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $21.3 Million - $34.1 Million	258,897 New	258,897 $25.3 Million

527

84.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.